Abstract

Synthetic polycations are studied extensively as DNA delivery agents because of their ease of production, good chemical stability, and low cost relative to viral vectors. This report describes the synthesis of charge-shifting polycations based on N,N-(dimethylamino)ethyl acrylate (DMAEA) and 3-aminopropylmethacryamide (APM), called PAD copolymers, and their use for in vitro DNA delivery into HeLa cells. PAD copolymers of varying compositions were prepared by RAFT polymerization to yield polymers of controlled molecular weights with low dispersities. Model hydrolysis studies were carried out to assess the rate of charge-shifting of the polycations by loss of the cationic dimethylaminoethanol side chains. They showed reduction in the net cationic charge by about 10–50% depending on composition after 2 days at pH 7, forming polyampholytes comprising permanent cationic groups, residual DMAEA, as well as anionic acrylic acid groups. HeLa cells exposed for 4 h to PAD copolymers with the greatest charge-shifting ability showed comparable or higher viability at high concentrations, relative to the noncharge shifting polycations PAPM and polyethyleneimine (PEI) 2 days post-exposure. Cell uptake efficiency of PAD/60bp-Cy3 DNA polyplexes at 2.5:1 N/P ratio was very high (>95%) for all compositions, exceeding the uptake efficiency of PEI polyplexes of equivalent composition. These results suggest that these PAD copolymers, and in particular PAD80 containing 80 mol % DMAEA, have suitable rates of charge-shifting hydrolysis for DNA delivery, as PAD80 showed reduced cytotoxicity at high concentrations, while still retaining high uptake efficiencies. In addition, the polyampholytes formed during DMAEA hydrolysis in PAD copolymers can offer enhanced long-term cytocompatibility.
Introduction
Polycations are used extensively in DNA delivery as nonviral vectors because of their ease of production, stability, and low cost, relative to lipid-based vectors.1−4 Although recent research has shown much promise in their ability to deliver nucleic acid payloads, there has been growing interest to develop polycations with further increased transfection efficiency and lower toxicity. Many studies involve probing the effect of various derivatives,5−7 molecular weight,8−12 polymer architecture,8,12−16 and polyplex morphology.17 Charge-shifting polycations have emerged as a class of polymers attracting significant interest as transfection agents.18−31 These polymers have high cationic charge densities but undergo a charge-shifting process, making the polymer less cationic. The initial high cationic charge density enables efficient binding and protection of anionic nucleic acids from nucleases, forming polyplexes. Following cellular uptake, the polyplexes can dissociate because of the charge shift of the polycation, releasing the genetic payload for intracellular delivery. Both charge-shifting and reducible polycations based on N,N-(dimethylamino)ethyl (meth)acrylate (DMAE(M)A) have shown promising DNA release capabilities and improved transfection efficiency.22,23,27,30−32 Further, the cytotoxicity of charge-shifting polycations was lower than that of standard synthetic polycations. This was attributed to the degradation of polymeric cationic charge and the release of byproducts such as dimethylaminoethanol (DMAE) that are nontoxic even at high concentrations.22,30 The cytotoxicity of polycations has been attributed to their interactions with critical anionic components of the cell including the phospholipid cell membrane and RNA/DNA, as well as their ability to trigger pro-apoptotic and pro-inflammatory signaling.33,34 Thus, charge-shifting polycations may be desirable alternatives to standard polycations as they can mitigate the accumulation of cytotoxic cationic charges.22,30,32 Recent findings have demonstrated that polyampholytes showed similar antifouling properties to zwitterionic polybetaines35 because of their surface hydration35,36 and have shown promising properties for transfection as the mixed surface charges are reminiscent of certain viruses.37 Thus, charge-shifting polycations that reduce their cationic charge to polyampholytes may be more cytocompatible than highly anionic polymers. The extent of cationic charge reduction can be controlled by copolymerization with another cationic monomer that does not undergo hydrolysis. Copolymerization has been used to control charge-shifting hydrolysis in previous studies,28,30,38,39 providing a useful handle to target such amphoteric materials.
While cellular uptake by different types of endocytosis is reasonably understood, the mechanism of endosomal escape of polyplexes or their DNA payload is still a topic of debate. One of the main theories rests on the “proton-sponge” effect of polycations,40,41 whereby polyplexes taken up by cells and contained within endosomes are acidified by fusion of endosomes with lysosomes. While the proton-sponge effect is commonly used to explain the mechanism of release in many polycation-mediated transfection systems, this hypothesis has been questioned42−44 and there is research indicating that endosomal escape of DNA may instead involve diffusion through defects in the endosomal membrane caused by interactions with the polycation.42,43 The lack of understanding of endosomal escape, including the role of the polycation, further demonstrates a need for new charge-shifting polycations to probe these processes; however, these studies will not be included in the current report. The work of this report will focus on the development and study of polycations based on DMAEA and will probe their potential in improving compatibility with cells while maintaining high uptake efficiencies. As for DMAEA homopolymers previously reported,22,23 these should degrade into nontoxic byproducts while retaining high uptake efficiencies.
The effect of charge-shifting hydrolysis on the cytotoxicity in polycation-mediated in vitro DNA delivery will be the focus of this study. In this report, we explore charge-shifting polycations based on DMAEA hydrolysis as potential DNA delivery agents with HeLa cells as a model cell line for which toxicity and delivery studies are commonly reported. In particular, poly[3-aminopropylmethacrylamide-co-N,N-(dimethylamino)ethyl acrylate] (PAD) copolymers38 with different mol % of DMAEA were used to study the effect of changing the charge-shifting potential of a series of polycations with constant initial charge density, on cytotoxicity and cellular uptake efficiency (Scheme 1).
Scheme 1. RAFT Polymerization of APM and DMAEA to Obtain Charge-Shifting PAD Copolymers that Undergo Hydrolysis with the Formation of Anionic Acrylic Acid (AA) Units.
PAD copolymers, initially highly cationic, complex anionic DNA to form polyplexes. Charge-shifting of PAD copolymers may facilitate intracellular DNA release because of weakening electrostatic interactions. The reduction in net cationic charge may also reduce cytotoxicity.
Experimental Section
Materials
DMAEA, (98%), 4-cyano-4-(phenylcarbonothioylthio)pentanoic acid (CTP, ≥98%), 4,4-azobis(4-cyanovaleric acid) (V-501, >97%), deuterium chloride (35% in D2O, 99% D), and WST-1 (Roche) were purchased from Sigma-Aldrich and used as received unless otherwise stated. Polyethyleneimine (PEI, branched, 25 kDa) was purchased from Sigma Aldrich, fractionated to obtain a lower molecular weight fraction (4–10 kDa) according to a previous report,45 and kindly provided by Susanne Przybylski at Fraunhofer IZI, Leipzig. (3-Aminopropyl)methacrylamide hydrochloride was purchased from PolySciences and was used as received. 1,4-Dioxane (≥99%) and 12 M HCl aq solution was purchased from Caledon Laboratories, basic alumina (activity I) from Fisher Scientific, and D2O (99.9% D) from Cambridge Isotope Laboratories Inc., and all were used as received. 60nt DNA forward and reverse strands were purchased from Biomers.net GmbH, Germany. Dulbecco’s modified Eagle medium (DMEM) (4.5 g/L glucose, no sodium pyruvate), Opti-MEM (HEPES, l-glutamine), fetal calf serum (FCS) (South American origin), and 1× Dulbecco’s PBS (DPBS) were purchased from Thermo Fisher Scientific. PE-Annexin V Apoptosis Detection Kit I (BD Pharmingen) was purchased from BD Biosciences.
Synthesis of PAD Copolymers
PAD copolymers of 80, 49, 23, and 0 (PAPM) relative mol % of DMAEA were prepared as described previously.38 Briefly, reversible addition–fragmentation chain-transfer (RAFT) polymerization of APM and DMAEA was conducted using CTP as the RAFT agent and V-501 as the initiator, targeting a molecular weight of 30,000 g/mol. In 20 mL screw cap vials, APM and DMAEA feeds of 15:85, 45:55, 75:25, and 100:0 mol ratios (1.8 g total monomer loading) were sequentially dissolved in 6 mL of a 2:1 water/1,4-dioxane solvent mixture with 1.1 mol equiv of HCl using a 6 M stock solution added relative to DMAEA. The dissolution of the monomers was carried out in an ice-water bath to remove the heat of neutralization of the monomers and to minimize premature hydrolysis of DMAEA. The reaction mixture was adjusted to pH 3–4 by addition of further HCl prior to the addition of CTP and V-501. Small magnetic stirring bars were added, and the vials were capped with septa. The reaction mixture was purged with N2 gas for 45 min at room temperature with stirring and then placed in an 80 °C oil bath. The polymerization proceeded until a targeted total monomer conversion of approximately 80% was reached as confirmed by 1H NMR, which required 1.5–2 h of heating depending on composition. The polymer solutions were dialyzed for 4–5 days against pH 3–4 distilled water using cellulose acetate tubing with a molecular weight cut-off of 3500 g/mol. Purified polymer solutions were freeze-dried, resulting in the polymers as their hydrochloride salt. Typical isolated yields were approximately 70–80%. 1H NMR spectra of PAD80, PAD49, PAD23, and PAPM in D2O are shown in Figures S1, S2, S3, and S4, respectively.
NMR Spectroscopy
1H NMR spectra were recorded on a Bruker AV600 or AV500 in D2O using the residual HDO/H2O signal at 4.80 ppm as the chemical shift reference.
Gel Permeation Chromatography
Gel permeation chromatography (GPC) of PAD copolymers was conducted using a Waters GPC consisting of a 717plus Autosampler, 515 HPLC pump, 2414 refractive index detector, Ultrahydrogel (120, 250, and 500) columns (30 cm × 7.8 mm (inner diameter); 6 μm particles) using poly[ethylene glycol] standards ranging from 106 Da to 881 kDa (Waters Inc.) for a 15-point, third-order polynomial calibration. The mobile phase was a 1 M acetic acid/sodium acetate buffer at pH 4.8.
Model Hydrolysis Studies
PAD copolymers were dissolved in 100 mM phosphate or acetate buffered solutions at pH 7 and 5, respectively, at a concentration of 0.5 wt %. Samples were maintained at room temperature (22 °C), and 1H NMR spectra were recorded at various time intervals. The pH of the PAD80, PAD49, PAD23, and PAPM of the phosphate buffered solutions just after dissolution were adjusted to pH 7.11, 7.06, 7.14, and 7.15, respectively, prior to analysis. The pH of the PAD80, PAD49, PAD23, and PAPM of the acetate-buffered solutions just after dissolution was adjusted to pH 5.03, 5.01, 4.99, and 5.00, respectively, prior to analysis. The pH did not drift significantly (less than 0.09 pH units) after hydrolysis. Hydrolysis percentages were calculated by comparing the integrations of the peaks at 3.9 and 4.5 ppm, corresponding to the CH2O methylene protons of small-molecule byproduct DMAE and remaining ester side chain of the polymer, respectively. A representative 1H NMR spectrum showing the integration and calculation of percent hydrolysis is shown in Figure S5.
Hybridization of DNA
60nt DNA forward and reverse strands (60nt-fw: 5′-NH2-GCTTTCTTCTCTAAATACATCTTCACGTCGATATCACCATAACTCAGGTAAGGAGGTCAA-3′; 60nt-fw-Cy3: 5′-Cy3-GCTTTCTTCTCTAAATACATCTTCACGTCGATATCACCATAACTCAGGTAAGGAGGTCAA-3′; 60nt-rv: 5′-TTGACCTCCTTACCTGAGTTATGGTGATATCGACGTGAAGATGTATTTAGAGAAGAAAGC-3′) were purchased from Biomers.net GmbH, Germany. Freeze-dried oligonucleotides were dissolved in Millipore water, and concentrations were measured by UV/vis spectroscopy using a NanoDrop ND-1000 Spectrophotometer from Peqlab Biotechnologie GmbH, Germany. Complimentary 60nt forward and reverse strands were combined in an equimolar ratio (relative to each strand) in 1× PBS. The oligonucleotides were hybridized using the following thermocycler program: 95 °C for 2 min, 71.6 °C for 15 min, following a drop to 4 °C. 60bp DNA labeled with Cy3 was prepared in the same procedure using a 60nt forward strand end-modified with a Cy3. 60bp and 60bp-Cy3 DNA solutions were stored at −20 °C and defrosted to room temperature prior to use.
Preparation of PAD–DNA Polyplexes
Polyplex solutions were prepared at 1:1, 2:1, 5:1, 10:1, and 20:1 mol ratios of polycation to DNA repeat units, resulting in ammonium cation nitrogen to phosphate anion (N/P) ratios of 0.5:1, 1:1, 2.5:1, 5:1, and 10:1, respectively. DNA solutions were prepared in Opti-MEM for a targeted final concentration of 300 nM according to the DNA strand. Polycation solutions were dissolved in DPBS and sterile-filtered through a 0.2 μm syringe filter prior to further dilutions, targeting the desired mol stoichiometry relative to DNA for equivolume mixing. For a typical transfection experiment in a 96-well plate, 50 μL of the DNA solution was added to each polycation solution (50 μL) and pipetted up and down vigorously 10 times using Greiner Bio-One filtered pipette tips. Polycation and polyplex solutions were prepared freshly prior to all transfection experiments.
Dynamic Light Scattering
Freshly prepared polyplex solutions as-formed (100 μL) were added to ZEN0400 microcuvettes for dynamic light scattering (DLS) measurements (n = 10) at room temperature with a Malvern Zetasizer Nano ZSP using a 173° backscatter angle.
Cell Culture
HeLa cells, purchased from the American Type Culture Collection (ATCC), USA, were cultured in DMEM (4.5 g/L glucose, without sodium pyruvate) containing 10% FCS. Cells were cultured as a monolayer at 37 °C in a humidified atmosphere with 5% CO2.
Transfection
HeLa cells were seeded into a tissue-cultured 96-well plate at a density of 10,000 cells per well. Plated cells were incubated for 2 days at 37 °C with 5% CO2 and reached approximately 70–80% confluency prior to transfection. Cells were washed with 100 μL 1× DPBS, and 100 μL of freshly prepared polyplex solution was added to each well. Each sample was prepared in triplicates. Following the addition of the polyplex solution, the plate was incubated at 37 °C with 5% CO2 for 4 h. The supernatant was removed, and the cells were washed with 100 μL of 1× DPBS to remove residual polyplexes, and 150 μL of FCS-containing DMEM were added to each well.
Cell Viability
Viability of transfected HeLa cells was measured after 1 and 2 days following transfection using the WST-1 cell proliferation assay. The assay was performed according to the supplier’s (Roche) protocol with minor modifications. Absorbance was measured after 1 h incubation at 37 °C using a Tecan Infinite M1000 plate reader at 450 nm, using 690 nm as the reference wavelength. Cells were incubated with 7% (v/v) DMSO in full medium as the positive control.
Cellular Uptake Efficiency
Cellular uptake of PAD–DNA (60bp-Cy3) polyplexes was measured by flow cytometry using an IntelliCyt iQue Screener. After 4 h of incubation, cells were washed with 1× DPBS to remove residual polyplexes, followed by the addition of 50 μL of 0.05% trypsin–EDTA solution and incubation at 37 °C for 3–5 min for cell detachment. FCS-containing DMEM (200 μL) was added to each well. The cell suspensions were transferred into 1.5 mL tubes and centrifuged at 1150 rpm for 5 min. The supernatant was discarded, and the cell pellet was resuspended in 100 μL of DMEM and then transferred into a 96-well v-bottom plate for analysis by flow cytometry. A minimum of 10,000 event counts was recorded for each sample. Measurements were analyzed using IntelliCyt ForeCyt software. Fluorescence of the populations was measured with the FL2 channel (585/40 nm). As cells uptake fluorescent polyplexes, there is an increase in fluorescence intensity relative to the autofluorescence of untreated cells. Autofluorescence gates were the same for all samples. Cellular uptake efficiency was represented as the percentage of cells showing Cy3 fluorescence relative to the autofluorescence of untreated HeLa cells.
Apoptosis Assay
The Annexin V Apoptosis Detection Kit I (BD Pharmingen) was used to identify cell populations as non-, early-, and late-stage apoptotic. During early-stage apoptosis, phosphatidylserine (PS) groups translocate from the inner leaflet to the outer leaflet of the plasma cell membrane. PE-Annexin V selectively binds to PS groups exposed on the outer leaflet of the cell membrane, indicating early-apoptosis. 7-Amino-actinomycin (7-AAD) is a counter stain that binds to double-stranded DNA in late-stage apoptotic cells that have compromised cell membranes. Thus, nonapoptotic cells do not stain positive for either PE-Annexin V or 7-AAD, early-apoptotic cells stain positive for only PE-Annexin V, and late-apoptotic cells stain positive for both PE-Annexin V and 7-AAD. A preliminary test was conducted on HeLa cells 1 day after exposure to 60bp DNA polyplexes with PAD copolymers and PEI at 1:1 and 10:1 N/P ratios. Cells were seeded in a 24-well plate at a density of 150,000 cells per well. Preparation of polyplexes and transfection of cells was performed as described for transfection in a 96-well plate. After 24 h, the supernatant of each well was collected into 1.5 mL microcentrifuge tubes prior to washing to retain dead cells for analysis that may be in suspension. Transfected cells were then washed with 1× DPBS and detached with 100 μL of 0.05% trypsin–EDTA after incubation at 37 °C for 3–5 min. FCS-containing DMEM (200 μL) was added to each well. The cell suspensions were transferred into microcentrifuge tubes containing the corresponding supernatant and centrifuged at 1150 rpm for 2.5 min. The cells were washed twice with ice-cold DPBS (100 μL) and resuspended in 100 μL of 1× Annexin binding buffer. The concentration of each cell suspension was determined using a Luna-II automated cell counter with Erythrosin B as the cell stain, and 100,000 cells of each sample were transferred to a 96-well v-bottom plate (total volume 50 μL per well). PE-Annexin V (5 μL) and 7-AAD (5 μL) were added to each well and incubated at room temperature for 20 min in the absence of light. Following incubation, the samples were measured by flow cytometry using an IntelliCyt iQue Screener. PE-Annexin V was detected using the FL2 channel (585/40 nm), and 7-AAD was detected using the FL3 channel (>670 nm) with 25% compensation to adjust for overlapping emission characteristics. Measurements were analyzed using IntelliCyt ForeCyt software. Gates for the apoptosis Annexin V and 7-AAD fluorescence were the same for all samples.
Statistical Analysis
Sample means were compared using a one-way ANOVA analysis with the Bonferroni post hoc test for multiple comparisons. Differences for which p < 0.05 were considered statistically significant.
Results and Discussion
Synthesis of PAD Copolymers
PAD80, PAD49, PAD23, and PAD0 with 80, 49, 23, and 0 mol % DMAEA, respectively, were synthesized using methods described previously.38 Herein, PAD0 will be referred to as PAPM and was synthesized as a control polycation that does not undergo charge-shifting hydrolysis. It was hypothesized that polyplexes made with charge-shifting polycations would be less toxic to HeLa cells relative to standard polycations such as PAPM and PEI, the latter is currently the gold standard polycation transfection agent. In particular, branched PEI of 25 kDa from Sigma-Aldrich was fractionated to obtain a lower molecular weight fraction (4–10 kDa) of PEI, which has shown higher transfection efficiency and lower toxicity in several cancer cell lines.45 Thus, the relative order of cytotoxicity was anticipated to be as follows: PAPM > PEI > PAD23 > PAD49 > PAD80. In addition, the polyampholytes with cationic/anionic charge ratios approaching 80/20, 49/51, and 23/77 formed by hydrolysis may be even more cell compatible than the corresponding polyacrylic acids formed during hydrolysis of DMAEA homopolymers described by Monteiro.22,23
RAFT polymerization to form the PAD copolymers resulted in reasonably low dispersities (Table 1), as well as controlled molecular weights as shown by their GPC traces in Figure 1. Properties of the PAD copolymers are summarized in Table 1, and their 1H NMR spectra are shown in Figures S1–S4.
Table 1. Properties of PAD Copolymers.
| polymer | [M]/[CTP]/[V-501] | conv. (%)a | Mn, NMRa (g/mol) | Mn, GPCb (g/mol) | D̵b | APM/DMAEAa |
|---|---|---|---|---|---|---|
| PAD80 | 209:1:0.22 | 90 | 40,100 | 26,600 | 1.26 | 20:80 |
| PAD49 | 204:1:0.17 | 92 | 32,200 | 27,200 | 1.38 | 51:49 |
| PAD23 | 206:1:0.17 | 81 | 29,700 | 28,100 | 1.39 | 77:23 |
| PAPM | 209:1:0.26 | 63 | 22,100 | 23,300 | 1.17 | 100:0 |
Data obtained from 1H NMR analysis in D2O with 1024 scans.
Data obtained from GPC analysis with 1 M acetic acid/sodium acetate buffer at pH 4.8 as the mobile phase, using PEG standards for molecular weight calibration.
Figure 1.

GPC traces of PAD80, PAD49, PAD23, and PAPM with a 1 M acetic acid/sodium acetate buffer at pH 4.8.
The Mn calculated by NMR end group analysis for PAD80 was higher than those for the other copolymers, which may be due to degradation of the end group during polymer purification. In this case, results obtained by GPC analysis would provide more accurate molecular weight information for polymer comparisons. In this study, polymer end groups were not removed because the toxicity of the cationic polymer typically outweighs the effect of the end group. However, it should be noted that end group removal might provide marginal improvements in cytocompatibility.46
Hydrolysis of PAD Copolymers
The hydrolysis of DMAEA groups in PAD80, PAD49, PAD23, and PAPM were monitored at pH 7 and room temperature (22 °C) by 1H NMR spectroscopy, and the results are shown in Figure 2 in terms of % hydrolysis of their respective initial DMAEA units. These conditions are approximations as in true transfection experiments; DMAEA hydrolysis will be affected by the presence of lipases, being part of a polyplex, and by the local pH ranging from pH 7 in media and cytosol to as low as pH 5 within lysosomes. In addition, an increase in temperature to 37 °C will also increase the rate of hydrolysis as shown previously for PAD copolymers and related DMAEA polymers.31,38
Figure 2.

Hydrolysis of PAD80, PAD49, PAD23, and PAPM at pH 7, room temperature (22 °C).
The hydrolysis of PAD copolymers at pH 7 is rapid initially, with all compositions showing first-order kinetics over the first day corresponding to half-life times of 2–3 days (Figure S6). After about one day, however, the rates of hydrolysis slow down for all compositions. This slower, second stage of hydrolysis was noted previously and was attributed to charge repulsion of hydroxide anions from anionic AA units formed after each DMAEA unit hydrolyses (Donnan exclusion).6,38,39,47,48
The data are replotted in terms of polymer net cationic charge % in Figure 3. The net cationic charge is defined here as the mol % cationic monomer—mol % anionic monomer or % APM + % DMAEA – % AA. For example, after approximately 2 days, all 3 polymers showed around 30% hydrolysis of their respective DMAEA groups (Figure 2), which corresponds to net cationic charges of about 55, 67, and 84% for PAD80, PAD49, and PAD23, respectively. After one week, the net cationic charges dropped to 31, 45, and 72% (Figure 3), respectively. As expected, PAPM did not show any hydrolysis even after 20 days (data not shown), as methacrylamides are much more hydrolytically stable than acrylates.
Figure 3.

Net cationic charge with hydrolysis of PAD80, PAD49, PAD23, and PAPM at pH 7, room temperature (22 °C).
The hydrolysis of PAD copolymers should be slow enough to allow for prior complexation with DNA to form polyplexes, followed by cellular uptake by interaction of the cationic polyplex with the cellular membrane. The latter would require the polymer to remain net cationic for at least 4 h, which is in line with the results obtained in Figures 2 and 3 that show less than 5% hydrolysis. During incubation after uptake of the polyplexes, the endosomes become more acidic (pH 4–5) by uptake of HCl and fusion with lysosomes. Under these conditions, DNA should ideally remain condensed in polyplexes for protection from lysosomal nucleases.21,23,30,31 This would make DMAEA hydrolysis ideal because we recently showed that DMAEA ester hydrolysis is slowed in the range of pH 3–5.38,39 The rate of hydrolysis of PAD copolymers at pH 5 was markedly slower than at pH 7, with all compositions showing approximately 16% hydrolysis after nearly 10 days (Figure S7). PAD copolymers may thus retain enough amino groups, both from APM as well as from DMAEA groups, for pH buffering as well as for disruption of the endosomal membrane to enable to escape by out-diffusion.24 Once the polyplexes have escaped from the endosomes, the environment of the cytosol with a pH of 7 should allow for accelerated hydrolysis of DMAEA units within PAD copolymers. We recently showed that in the presence of adequate amounts of buffer, the rates of hydrolysis of DMAEA units in such copolymers increase significantly with pH.38,39 The release of DNA from the polyplexes may then occur in the cytosol, during transport to the nucleus, or in the nucleus itself. In addition to providing a potential release mechanism for DNA, charge-shifting hydrolysis may reduce the long-term cytotoxicity of the polymer by decreasing the polymeric cationic charge. In the present work, the size and cellular uptake efficiencies of DNA polyplexes incorporating a range of charge-shifting PAD copolymers were assessed, and the viability of cells after exposure to charge-shifting PAD copolymers determined using standard polycations as controls. The hydrolysis experiment serves as a model to better understand the effect of pH in the complex intracellular environment and provides useful insights toward polymer stability for further mechanistic studies.
Size Determination of Polyplexes
DLS was used to measure the size of polyplexes made from PAD copolymers and 60bp DNA. Polyplex solutions were prepared using the same procedure as a transfection experiment with no further dilutions. Polyplexes made with PAD copolymers and PEI all showed broad size distributions, as shown in a representative graph for the 2.5:1 N/P ratio (Figure 4). The results for the range of concentrations are summarized in Figure 5.
Figure 4.

Size distribution for polyplexes of PAD copolymers, PAPM, and PEI with 60bp DNA at a 5:1 mol ratio, from DLS.
Figure 5.

Diameters of Polyplexes of PAD copolymers, PAPM, and PEI with 60bp DNA at 1:1, 2.5:1, 5:1, and 10:1 N/P ratios, determined using DLS. Error bars represent the standard deviation from 2 polyplex batches with 10 measurements each.
The average diameters of the polyplexes ranged from 400 to 1400 nm. At the 1:1 N/P ratio, the polyplexes were similar between all of the polymers around 1100 nm. However, at higher polymer loadings, polyplexes with DMAEA-rich PAD copolymers (i.e., PAD80) resulted in smaller particles (∼700 nm) than those with DMAEA-poor PAD copolymers and PAPM (∼1400 nm). This trend may be due to the different interactions of tertiary and primary ammonium cations of the polymers with phosphate anions of DNA. The relatively large size of polyplexes obtained may also be due to the overall concentration used during complexation and can be changed to obtain smaller particles. Although the size of polyplexes is known to affect cellular uptake, many other variables can affect cellular uptake that go beyond the scope of this report.49 Thus, the effects of polyplex diameters on cell uptake and viability were not further explored in this study.
Cell Viability
Cell viability of HeLa cells after 1 and 2 days post-exposure to the polyplexes was measured using the WST-1 proliferation assay (Figures 6 and 7, respectively).
Figure 6.

HeLa cell viability one day post-exposure to 60bp DNA with PAD copolymers, PAPM, and PEI at 1:1, 2.5:1, 5:1, and 10:1 N/P ratios. HeLa cells were treated with DMSO [7% (v/v) in FCS-containing DMEM] as a positive control.
Figure 7.

HeLa cell viability two days after exposure to polyplexes of 60bp DNA with PAD copolymers, PAPM, and PEI at 1:1, 2.5:1, 5:1, and 10:1 N/P ratios. HeLa cells were treated with DMSO [7% (v/v) in FCS-containing DMEM] as the positive control. Statistical significance for PAD copolymer samples at 5:1 and 10:1 N/P ratios are shown. *p ≤ 0.05, **p ≤ 0.01, ****p ≤ 0.0001.
One day after exposure to the polyplexes, viability of HeLa cells appeared to decrease with increasing polycation concentrations for all of the polymers. There is no discernible effect of APM/DMAEA ratios, while PEI shows higher cell viabilities than the PAD copolymers. Interestingly, two days after exposure to polyplexes, viability of HeLa cells shows an effect of PAD composition: HeLa cells treated with PAD80 showed higher viabilities than cells treated with PAD49, PAD23, and PAPM. This effect was more pronounced for polymer/DNA ratios of 5:1 and 10:1 N/P.
Similar viability results across the range of compositions of PAD copolymers after one day are not surprising given the relatively slow rate of charge-shifting hydrolysis. Because PAD copolymers maintain enough cationic charge to bind DNA, it is likely that the initial net cationic charge of the polyplexes that cells are exposed to would be similar for all PAD copolymers. Thus, the initial cytotoxicity for the polyplexes, and any excess free polycation, should be similar for the different compositions. This seems to be the challenge in the field of synthetic polymers for transfection as the cationic charge is necessary for the condensation and uptake of DNA; however, the polymers are also cytotoxic at high concentrations due to disruption of the cellular membrane.
After two days post-exposure, viability appeared to be higher for cells exposed to polyplexes made from PAD copolymers with greater charge-shifting ability. In some cases, particularly at lower N/P ratios, cells treated with polyplexes showed viabilities greater than untreated cells (i.e., viability > 100%). It is unclear why this was the case; however, the trends observed between polymer composition and concentration (N/P ratios) remain evident. The results suggest that cells are better able to recover after exposures to these copolymers, which may be due to the degradation of the cytotoxic cationic charge. Hydrolysis data showed that after two days, the net charge of PAD80, PAD49, and PAD23 were approximately 55, 67, and 84% net cationic, respectively (Figure 2). Thus, it is likely that improved recovery of cell viability may be due to the charge-shifting hydrolysis of the PAD copolymers. This trend matches that observed by other researchers for related charge-shifting polycations.22,27 Given the poor cell viability observed at the 10:1 N/P ratio for all polycations, subsequent transfection experiments were conducted at more optimal concentrations (1:1, 2.5:1, and 5:1 N/P ratios).
Cellular Uptake
HeLa cells were exposed to polyplexes made from PAD copolymers, PAPM, and PEI with DNA fluorescently labeled with Cy3 (60bp-Cy3). The cells were analyzed by flow cytometry following the 4 h incubation period with polyplexes. Gating examples of the dot plots obtained are provided in the Supporting Information (Figures S8–S13), and the results are summarized in Figure 8.
Figure 8.

Cellular uptake efficiency of 60bp-Cy3 DNA with PAD copolymers, PAPM, and PEI at 1:1, 2.5:1, and 5:1 N/P ratios, respectively.
Uptake efficiency of 60bp-Cy3 DNA at the 1:1 N/P ratio is higher for PAPM than the PAD copolymers. The nominal net charge of the polyplex with the 2:1 PAD to DNA mol ratio should be neutral; however, as some hydrolysis has occurred, it may actually be slightly negative. This may be why the uptake efficiency of PAPM polyplexes is higher at this low polycation/DNA ratio, as endocytosis of neutral particles would be more likely than of anionic particles.
At the 2.5:1 N/P ratio, uptake efficiency appeared to be very high (>95%) for all PAD copolymers and PAPM. At 5:1 N/P, uptake efficiency of PAD80 polyplexes remained high at 92%; however, uptake efficiency began to decrease for PAD copolymers containing less DMAEA. Similarly, only 70% of the cells showed fluorescence when treated with PAPM polyplexes at 5:1 N/P. These decreases in cellular uptake efficiency correlate with the cytotoxicity data obtained using the WST-1 assay. HeLa cells treated with PAD copolymer polyplexes richer in APM showed a subpopulation that was thought to correspond to apoptotic cells. This was confirmed by conducting an Annexin V apoptosis assay at 1:1 and 10:1 N/P ratios that showed a high percentage of apoptotic cells (>80%) in this subpopulation (Figures S14–S16). As this subpopulation was more prominent at higher concentrations (10:1 N/P), this is in agreement with the increased cytotoxicity observed at higher polymer concentrations from the WST-1 assay. Thus, the decrease in cellular uptake efficiency of PAPM correlates with the toxicity of the corresponding polyplexes. This could be due to cationic charges of PAPM and PAPM-rich polyplexes that are unable to undergo charge-shifting hydrolysis, causing cell death and thereby reducing the number of cells in the region of healthy, fluorescent cells. Similarly, PAD80 polyplexes showed the highest uptake efficiency at the 5:1 N/P, which may be due to PAD80 having the greatest charge-shifting ability and hence a greater proportion of healthy, Cy3-positive cells.
Cellular uptake efficiency of PEI polyplexes appeared to be significantly lower than PAD copolymer polyplexes at 1:1 and 2.5:1 N/P ratios (Figure 8). At the highest, 5:1 N/P ratio, PEI shows comparable uptake efficiency to PAD copolymers used at the 2.5:1 ratio. These results for PAD copolymers are promising as PEI is currently the gold-standard polycation used in the field because of its high transfection efficiency.
Conclusions
PAD copolymers of varying compositions were synthesized by RAFT polymerization to obtain polymers with controlled molecular weights and dispersities. Model hydrolysis studies of the polymers using 1H NMR spectroscopy provided useful information on the evolution of the net charge of the polymers at pH 7, suggesting a route for potential intracellular dissociation of complexed DNA for controlled release from PAD80 and PAD49 polyplexes. HeLa cells transfected with PAD copolymer polyplexes showed very high viability at the 1:1 and 2.5:1 N/P ratios of all of the compositions. However, at higher polymer loadings, HeLa cells transfected with PAD copolymers of higher DMAEA composition showed higher viability than cells treated with noncharge-shifting PAPM. The higher viability associated with PAD copolymers is correlated to the charge-shifting ability of the polymers which likely reduces cytotoxicity, particularly long-term, as cells recovered well 2 days after exposure. Cellular uptake efficiency of PAD copolymer polyplexes was very high (>95%) at the 2.5:1 N/P ratio, out-performing PEI polyplexes which required double the polycation loading to achieve a similar level of uptake efficiency. Overall, PAD copolymers of higher DMAEA content (PAD80 and PAD49) used at the 2.5:1 N/P ratio appear as promising candidates for further cell transfection experiments including gene expression.
In conclusion, the findings in this report suggest that charge-shifting cationic copolymers are a promising class of synthetic polymers suitable for in vitro DNA delivery. Future work will involve exploring gene transfection efficiency and mechanism of intracellular release of DNA from polyplexes with these charge-shifting copolymers, both with HeLa and other cell lines.
Acknowledgments
H.D.H.S. and S.R. are grateful for funding support from the Canada Foundation for Innovation and the Natural Sciences and Engineering Research Council of Canada Discovery Grant (RGPIN89661-11). S.R. received funding support from Mitacs through a Globalink Research Award and an Ontario Graduate Scholarship. S.R. thanks Christin Möser and Martin Sajfutdinow for help with flow cytometry and DLS measurements, respectively. Susanne Przybylski is acknowledged for generously providing the sample of PEI. Robel Belay is acknowledged for testing HeLa cell cultures for mycoplasma.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.9b03734.
1H NMR spectra of PAD80, PAD49, PAD23, and PAPM; 1H NMR spectrum of a representative example of hydrolysis showing integration and calculation of percent hydrolysis; first-order kinetic plot of PAD copolymer hydrolysis; hydrolysis plot of PAD copolymers and PAPM at pH 5; dot plots from flow cytometry analysis of cellular uptake of 60bp-Cy3 DNA polyplexes; dot plots from flow cytometry analysis of apoptosis assay post-exposure to PAD80–60bp polyplexes at 1:1 and 10:1 N/P ratios, and untreated cells (PDF)
The authors declare no competing financial interest.
Supplementary Material
References
- Agarwal S.; Zhang Y.; Maji S.; Greiner A. PDMAEMA based gene delivery materials. Mater. Today 2012, 15, 388–393. 10.1016/s1369-7021(12)70165-7. [DOI] [Google Scholar]
- Thomas M.; Klibanov A. M. Non-viral gene therapy: polycation-mediated DNA delivery. Appl. Microbiol. Biotechnol. 2003, 62, 27–34. 10.1007/s00253-003-1321-8. [DOI] [PubMed] [Google Scholar]
- Pollard H.; Remy J.-S.; Loussouarn G.; Demolombe S.; Behr J.-P.; Escande D. Polyethylenimine but Not Cationic Lipids Promotes Transgene Delivery to the Nucleus in Mammalian Cells. J. Biol. Chem. 1998, 273, 7507–7511. 10.1074/jbc.273.13.7507. [DOI] [PubMed] [Google Scholar]
- Kabanov A. V.; Kabanov V. A. DNA Complexes with Polycations for the Delivery of Genetic Materials into Cells. Bioconjugate Chem. 1995, 6, 7–20. 10.1021/bc00031a002. [DOI] [PubMed] [Google Scholar]
- Luten J.; van Nostrum C. F.; De Smedt S. C.; Hennink W. E. Biodegradable polymers as non-viral carriers for plasmid DNA delivery. J. Controlled Release 2008, 126, 97–110. 10.1016/j.jconrel.2007.10.028. [DOI] [PubMed] [Google Scholar]
- van de Wetering P.; Moret E. E.; Schuurmans-Nieuwenbroek N. M. E.; van Steenbergen M. J.; Hennink W. E. Structure-Activity Relationships of Water-Soluble Cationic Methacrylate/Methacrylamide Polymers for Nonviral Gene Delivery. Bioconjugate Chem. 1999, 10, 589–597. 10.1021/bc980148w. [DOI] [PubMed] [Google Scholar]
- Ong Z. Y.; Yang C.; Cheng W.; Voo Z. X.; Chin W.; Hedrick J. L.; Yang Y. Y. Biodegradable cationic poly(carbonates): Effect of varying side chain hydrophobicity on key aspects of gene transfection. Acta Biomater. 2017, 54, 201–211. 10.1016/j.actbio.2017.03.027. [DOI] [PubMed] [Google Scholar]
- Eltoukhy A. A.; Siegwart D. J.; Alabi C. A.; Rajan J. S.; Langer R.; Anderson D. G. Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity. Biomaterials 2012, 33, 3594–3603. 10.1016/j.biomaterials.2012.01.046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ahmed M.; Narain R. The effect of polymer architecture, composition, and molecular weight on the properties of glycopolymer-based non-viral gene delivery systems. Biomaterials 2011, 32, 5279–5290. 10.1016/j.biomaterials.2011.03.082. [DOI] [PubMed] [Google Scholar]
- Godbey W. T.; Wu K. K.; Mikos A. G. Size matters: Molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J. Biomed. Mater. Res., Part B 1998, 45, 268–275. . [DOI] [PubMed] [Google Scholar]
- van de Wetering P.; Cherng J.-Y.; Talsma H.; Crommelin D. J. A.; Hennink W. E. 2-(dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J. Controlled Release 1998, 53, 145–153. 10.1016/s0168-3659(97)00248-4. [DOI] [PubMed] [Google Scholar]
- Synatschke C. V.; Schallon A.; Jérôme V.; Freitag R.; Müller A. H. E. Influence of Polymer Architecture and Molecular Weight of Poly(2-(dimethylamino)ethyl methacrylate) Polycations on Transfection Efficiency and Cell Viability in Gene Delivery. Biomacromolecules 2011, 12, 4247–4255. 10.1021/bm201111d. [DOI] [PubMed] [Google Scholar]
- Kadlecova Z.; Baldi L.; Hacker D.; Wurm F. M.; Klok H.-A. Comparative Study on the In Vitro Cytotoxicity of Linear, Dendritic, and Hyperbranched Polylysine Analogues. Biomacromolecules 2012, 13, 3127–3137. 10.1021/bm300930j. [DOI] [PubMed] [Google Scholar]
- Srinivasachari S.; Fichter K. M.; Reineke T. M. Polycationic β-Cyclodextrin “Click Clusters”: Monodisperse and Versatile Scaffolds for Nucleic Acid Delivery. J. Am. Chem. Soc. 2008, 130, 4618–4627. 10.1021/ja074597v. [DOI] [PubMed] [Google Scholar]
- Yin M.; Ding K.; Gropeanu R. A.; Shen J.; Berger R.; Weil T.; Müllen K. Dendritic star polymers for efficient DNA binding and stimulus-dependent DNA release. Biomacromolecules 2008, 9, 3231–3238. 10.1021/bm800797j. [DOI] [PubMed] [Google Scholar]
- Rinkenauer A. C.; Schubert S.; Traeger A.; Schubert U. S. The influence of polymer architecture on in vitro pDNA transfection. J. Mater. Chem. B 2015, 3, 7477–7493. 10.1039/c5tb00782h. [DOI] [PubMed] [Google Scholar]
- Shi J.; Choi J. L.; Chou B.; Johnson R. N.; Schellinger J. G.; Pun S. H. Effect of Polyplex Morphology on Cellular Uptake, Intracellular Trafficking, and Transgene Expression. ACS Nano 2013, 7, 10612–10620. 10.1021/nn403069n. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lim Y.-B.; Choi Y. H.; Park J.-S. A Self-Destroying Polycationic Polymer: Biodegradable Poly(4-hydroxy-L-proline ester). J. Am. Chem. Soc. 1999, 121, 5633–5639. 10.1021/ja984012k. [DOI] [Google Scholar]
- Putnam D.; Langer R. Poly(4-hydroxy-L-proline ester): Low-Temperature Polycondensation and Plasmid DNA Complexation. Macromolecules 1999, 32, 3658–3662. 10.1021/ma982004i. [DOI] [Google Scholar]
- Liu X.; Yang J. W.; Miller A. D.; Nack E. A.; Lynn D. M. Charge-Shifting Cationic Polymers That Promote Self-Assembly and Self-Disassembly with DNA. Macromolecules 2005, 38, 7907–7914. 10.1021/ma051270a. [DOI] [Google Scholar]
- Luten J.; Akeroyd N.; Funhoff A.; Lok M. C.; Talsma H.; Hennink W. E. Methacrylamide Polymers with Hydrolysis-Sensitive Cationic Side Groups as Degradable Gene Carriers. Bioconjugate Chem. 2006, 17, 1077–1084. 10.1021/bc060068p. [DOI] [PubMed] [Google Scholar]
- Truong N. P.; Jia Z.; Burges M.; McMillan N. A. J.; Monteiro M. J. Self-Catalyzed Degradation of Linear Cationic Poly(2- dimethylaminoethyl acrylate) in Water. Biomacromolecules 2011, 12, 1876–1882. 10.1021/bm200219e. [DOI] [PubMed] [Google Scholar]
- Truong N. P.; Jia Z.; Burgess M.; Payne L.; McMillan N. A. J.; Monteiro M. J. Self-Catalyzed Degradable Cationic Polymer for Release of DNA. Biomacromolecules 2011, 12, 3540–3548. 10.1021/bm2007423. [DOI] [PubMed] [Google Scholar]
- Truong N. P.; Gu W.; Prasadam I.; Jia Z.; Crawford R.; Xiao Y.; Monteiro M. J. An influenza virus-inspired polymer system for the timed release of siRNA. Nat. Commun. 2013, 4, 1902. 10.1038/ncomms2905. [DOI] [PubMed] [Google Scholar]
- Novo L.; Rizzo L. Y.; Golombek S. K.; Dakwar G. R.; Lou B.; Remaut K.; Mastrobattista E.; van Nostrum C. F.; Jahnen-Dechent W.; Kiessling F.; Braeckmans K.; Lammers T.; Hennink W. E. Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy. J. Controlled Release 2014, 195, 162–175. 10.1016/j.jconrel.2014.08.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ho H. T.; Pascual S.; Montembault V.; Casse N.; Fontaine L. Innovative well-defined primary amine-based polyacrylates for plasmid DNA complexation. Polym. Chem. 2014, 5, 5542–5545. 10.1039/c4py00585f. [DOI] [Google Scholar]
- Werfel T. A.; Swain C.; Nelson C. E.; Kilchrist K. V.; Evans B. C.; Miteva M.; Duvall C. L. Hydrolytic charge-reversal of PEGylated polyplexes enhances intracellular un-packaging and activity of siRNA. J. Biomed. Mater. Res., Part A 2016, 104, 917–927. 10.1002/jbm.a.35629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ho H. T.; Bohec M. L.; Frémaux J.; Piogé S.; Casse N.; Fontaine L.; Pascual S. Tuning the Molar Composition of “Charge-Shifting” Cationic Copolymers Based on 2-(N,N-Dimethylamino)Ethyl Acrylate and 2-(tert-Boc-Amino)Ethyl Acrylate. Macromol. Rapid Commun. 2017, 38, 1600641. 10.1002/marc.201600641. [DOI] [PubMed] [Google Scholar]
- Qiu N.; Gao J.; Liu Q.; Wang J.; Shen Y. Enzyme-Responsive Charge-Reversal Polymer-Mediated Effective Gene Therapy for Intraperitoneal Tumors. Biomacromolecules 2018, 19, 2308–2319. 10.1021/acs.biomac.8b00440. [DOI] [PubMed] [Google Scholar]
- Cook A. B.; Peltier R.; Hartlieb M.; Whitfield R.; Moriceau G.; Burns J. A.; Haddleton D. M.; Perrier S. Cationic and hydrolysable branched polymers by RAFT for complexation and controlled release of dsRNA. Polym. Chem. 2018, 9, 4025–4035. 10.1039/c8py00804c. [DOI] [Google Scholar]
- Whitfield R.; Anastasaki A.; Truong N. P.; Cook A. B.; Omedes-Pujol M.; Loczenski Rose V.; Nguyen T. A. H.; Burns J. A.; Perrier S.; Davis T. P.; Haddleton D. M. Efficient Binding, Protection, and Self-Release of dsRNA in Soil by Linear and Star Cationic Polymers. ACS Macro Lett. 2018, 7, 909–915. 10.1021/acsmacrolett.8b00420. [DOI] [PubMed] [Google Scholar]
- You Y.-Z.; Manickam D. S.; Zhou Q.-H.; Oupický D. Reducible poly(2-dimethylaminoethyl methacrylate): Synthesis, cytotoxicity, and gene delivery activity. J. Controlled Release 2007, 122, 217–225. 10.1016/j.jconrel.2007.04.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lonez C.; Vandenbranden M.; Ruysschaert J.-M. Cationic lipids activate intracellular signaling pathways. Adv. Drug Delivery Rev. 2012, 64, 1749–1758. 10.1016/j.addr.2012.05.009. [DOI] [PubMed] [Google Scholar]
- Cobourn R. F. Polyamine Effects on Cell Function: Possible Central Role of Plasma Membrane PI(4,5)P2. J. Cell. Physiol. 2009, 221, 544–551. 10.1002/jcp.21899. [DOI] [PubMed] [Google Scholar]
- Leng C.; Huang H.; Zhang K.; Hung H.-C.; Xu Y.; Li Y.; Jiang S.; Chen Z. Effect of Surface Hydration on Antifouling Properties of Mixed Charged Polymers. Langmuir 2018, 34, 6538–6545. 10.1021/acs.langmuir.8b00768. [DOI] [PubMed] [Google Scholar]
- Chen S.; Li L.; Zhao C.; Zheng J. Surface hydration: Principles and applications toward low-fouling/nonfouling biomaterials. Polymer 2010, 51, 5283–5293. 10.1016/j.polymer.2010.08.022. [DOI] [Google Scholar]
- Rinkenauer A. C.; Schallon A.; Günther U.; Wagner M.; Betthausen E.; Schubert U. S.; Schacher F. H. A Paradigm Change: Efficient Transfection of Human Leukemia Cells by Stimuli-Responsive Multicompartment Micelles. ACS Nano 2013, 7, 9621–9631. 10.1021/nn402072d. [DOI] [PubMed] [Google Scholar]
- Ros S.; Burke N. A. D.; Stöver H. D. H. Synthesis and Properties of Charge-Shifting Polycations: Poly[3-aminopropylmethacrylamide-co-2-(dimethylamino)ethyl acrylate]. Macromolecules 2015, 48, 8958–8970. 10.1021/acs.macromol.5b02191. [DOI] [Google Scholar]
- Ros S.; Kleinberger R. M.; Burke N. A. D.; Rossi N. A. A.; Stöver H. D. H. Charge-Shifting Polycations with Tunable Rates of Hydrolysis: Effect of Backbone Substituents on Poly[2-(dimethylamino)ethyl acrylates]. Macromolecules 2018, 51, 5752–5761. 10.1021/acs.macromol.8b00931. [DOI] [Google Scholar]
- Behr J. P. The Proton Sponge: a Trick to Enter Cells the Viruses Did Not Exploit. Chimia 1997, 51, 34–36. [Google Scholar]
- Akinc A.; Thomas M.; Klibanov A. M.; Langer R. Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 2005, 7, 657–663. 10.1002/jgm.696. [DOI] [PubMed] [Google Scholar]
- Dubruel P.; Christiaens B.; Rosseneu M.; Vandekerckhove J.; Grooten J.; Goossens V.; Schacht E. Buffering Properties of Cationic Polymethacrylates Are Not the Only Key to Successful Gene Delivery. Biomacromolecules 2004, 5, 379–388. 10.1021/bm034438d. [DOI] [PubMed] [Google Scholar]
- Benjaminsen R. V.; Mattebjerg M. A.; Henriksen J. R.; Moghimi S. M.; Andresen T. L. The Possible “Proton Sponge” Effect of Polyethylenimine (PEI) Does Not Include Change in Lysosomal pH. Mol. Ther. 2013, 21, 149–157. 10.1038/mt.2012.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gabrielson N. P.; Pack D. W. Acetylation of Polyethylenimine Enhances Gene Delivery via Weakened Polymer/DNA Interactions. Biomacromolecules 2006, 7, 2427–2435. 10.1021/bm060300u. [DOI] [PubMed] [Google Scholar]
- Werth S.; Urban-Klein B.; Dai L.; Höbel S.; Grzelinski M.; Bakowsky U.; Czubayko F.; Aigner A. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes. J. Controlled Release 2006, 112, 257–270. 10.1016/j.jconrel.2006.02.009. [DOI] [PubMed] [Google Scholar]
- Pissuwan D.; Boyer C.; Gunasekaran K.; Davis T. P.; Bulmus V. In Vitro Cytotoxicity of RAFT Polymers. Biomacromolecules 2010, 11, 412–420. 10.1021/bm901129x. [DOI] [PubMed] [Google Scholar]
- Rolph M. S.; Pitto-Barry A.; O’Reilly R. K. The hydrolytic behavior of N,N′-(dimethylamino) ethyl acrylate-functionalized polymeric stars. Polym. Chem. 2017, 8, 5060–5070. 10.1039/c7py00219j. [DOI] [Google Scholar]
- Higuchi M.; Senju R. Kinetic Aspects of Alkaline Hydrolysis of Poly(acrylamide). Polym. J. 1972, 3, 370–377. 10.1295/polymj.3.370. [DOI] [Google Scholar]
- Pezzoli D.; Giupponi E.; Mantovani D.; Candiani G. Size matters for in vitro gene delivery: investigating the relationships among complexation protocol, transfection medium, size and sedimentation. Sci. Rep. 2017, 7, 44134. 10.1038/srep44134. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

